SOL Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

SOL Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,710	Closed	-$991K	–	275
2025 Q4	$991K	Buy	1,710 +150	+10%	+$84.8K	0.09%	174
2025 Q3	$757K	Buy	1,560 +140	+10%	+$65.2K	0.07%	194
2025 Q2	$576K	Buy	1,420 +372	+35%	+$156K	0.06%	219
2025 Q1	$521K	Hold	1,048	–	–	0.06%	223
2024 Q4	$545K	Sell	1,048 -1,000	-49%	-$550K	0.06%	216
2024 Q3	$1.27M	Hold	2,048	–	–	0.14%	143
2024 Q2	$1.13M	Hold	2,048	–	–	0.14%	152
2024 Q1	$1.19M	Hold	2,048	–	–	0.15%	145
2023 Q4	$1.09M	Hold	2,048	–	–	0.15%	146
2023 Q3	$1.04M	Sell	2,048 -20	-1%	-$10.7K	0.16%	144
2023 Q2	$1.08M	Hold	2,068	–	–	0.16%	139
2023 Q1	$1.19M	Hold	2,068	–	–	0.2%	132
2022 Q4	$1.14M	Hold	2,068	–	–	0.2%	128
2022 Q3	$1.05M	Hold	2,068	–	–	0.22%	119
2022 Q2	$1.12M	Buy	2,068 +43	+2%	+$23.7K	0.23%	119
2022 Q1	$1.2M	Hold	2,025	–	–	0.22%	119
2021 Q4	$1.35M	Hold	2,025	–	–	0.24%	106
2021 Q3	$1.16M	Hold	2,025	–	–	0.23%	104
2021 Q2	$1.02M	Hold	2,025	–	–	0.2%	111
2021 Q1	$924K	Sell	2,025 -77	-4%	-$36.8K	0.2%	114
2020 Q4	$979K	Hold	2,102	–	–	0.23%	105
2020 Q3	$928K	Sell	2,102 -100	-5%	-$41.3K	0.26%	104
2020 Q2	$798K	Hold	2,202	–	–	0.23%	106
2020 Q1	$624K	Hold	2,202	–	–	0.21%	112
2019 Q4	$715K	Hold	2,202	–	–	0.18%	127
2019 Q3	$641K	Sell	2,202 -109	-5%	-$31.2K	0.18%	132
2019 Q2	$679K	Hold	2,311	–	–	0.18%	133
2019 Q1	$633K	Hold	2,311	–	–	0.18%	138
2018 Q4	$517K	Sell	2,311 -35	-1%	-$8.21K	0.17%	144
2018 Q3	$573K	Hold	2,346	–	–	0.15%	146
2018 Q2	$486K	Sell	2,346 -50	-2%	-$10.6K	0.14%	154
2018 Q1	$495K	Buy	2,396 +87	+4%	+$18.3K	0.14%	158
2017 Q4	$438K	Sell	2,309 -1,000	-30%	-$192K	0.13%	164
2017 Q3	$626K	Buy	3,309 +124	+4%	+$22.5K	0.18%	136
2017 Q2	$556K	Sell	3,185 -65	-2%	-$10.9K	0.15%	152
2017 Q1	$499K	Hold	3,250	–	–	0.14%	146
2016 Q4	$459K	Hold	3,250	–	–	0.14%	145
2016 Q3	$517K	Hold	3,250	–	–	0.17%	124
2016 Q2	$480K	Hold	3,250	–	–	0.16%	123
2016 Q1	$460K	Hold	3,250	–	–	0.16%	128
2015 Q4	$461K	Sell	3,250 -100	-3%	-$13.3K	0.16%	127
2015 Q3	$410K	Hold	3,350	–	–	0.16%	130
2015 Q2	$435K	Hold	3,350	–	–	0.16%	125
2015 Q1	$450K	Hold	3,350	–	–	0.17%	125
2014 Q4	$420K	Hold	3,350	–	–	0.16%	121
2014 Q3	$408K	Hold	3,350	–	–	0.17%	121
2014 Q2	$395K	Hold	3,350	–	–	0.16%	123
2014 Q1	$403K	Hold	3,350	–	–	0.16%	120
2013 Q4	$373K	Hold	3,350	–	–	0.14%	124
2013 Q3	$309K	Sell	3,350 -400	-11%	-$36.2K	0.13%	135
2013 Q2	$317K	Buy	+3,750	New	+$312K	0.13%	133

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SOL Capital Management's TMO Position: Q1 2026 in Review

SOL Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 1,710 shares — an estimated $991K sold.

SOL Capital Management first reported a position in TMO in Q2 2013 and held it in 51 quarters. The position peaked at $1.35M in Q4 2021. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

SOL Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
SOL Capital Management sold 1,710 Thermo Fisher Scientific shares in Q1 2026, an estimated $991K.
SOL Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 51 quarters.
SOL Capital Management's Thermo Fisher Scientific position peaked at $1.35M in Q4 2021.
2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on SOL Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.